Delphi Helps Homecare Agencies and Patients Stay Connected

TROY, Mich. — Delphi Corporation (PINKSHEETS: DPHIQ) is helping patients and their healthcare providers stay connected with the Delphi Medical Systems Telehealth System.

“Delphi’s Telehealth System allows for remote monitoring of a patient’s vital signs,” said Dave Berge, managing director, Delphi Medical Systems. “This is a powerful, easy-to-use tool that allows caregivers and patients peace of mind that their current condition is being assessed even when a nurse or doctor has not visited their home.”

Delphi’s Telehealth System is an intelligent monitoring system that allows healthcare providers to monitor patient vital signs without an office or home visit. Instead, patients can use the Delphi VitalPoint Home Monitor to quickly and easily check non-invasive blood pressure, oxygen saturation/pulse oximetry, temperature, pulse rate, weight, blood glucose, ECG, prothrombin time and thoracic fluid status. Once levels are recorded, the information is automatically sent via telephone line to a safe and secure Delphi server. The patient’s authorized professional care providers can then monitor the information on a computer in their office or on a PDA or cell phone if they are in the field. The system is HIPAA-compliant and completely secure.

The patient’s own care providers analyze the regular patient data to catch early signs and predictors of health issues that can be quickly corrected with changes in the patient’s care plan. Often early warning of vital sign changes and corrective intervention can help keep patients at home, avoiding hospital, office or urgent care visits.

“This easy-to-use, intuitive system does not require an internet connection or computer-use by the patient or a dedicated server by the healthcare provider,” Berge said. “It is a cost-effective way for agencies to monitor patient status and for patients to communicate with caregivers without an office or home visit.”

At the center of the system is the Delphi VitalPoint Home Monitor and peripherals including thermometer, blood pressure cuff, pulse oximeter, glucometer, ECG/EKG and weight scale. This lightweight monitor features a large touch-screen that displays detailed reminders of scheduled vital signs activities and/or medication dosage schedules. A clear-voice audio prompt accompanies the reminder. VitalPoint can also display any messages from caregivers or allow patients to report any non-emergency symptom to caregivers.

For example, patients with Congestive Heart Failure could have a monitor in their home that would remind them to take certain vital sign measurements specific to the management of their condition at certain times of the day. It can also be utilized by the patient’s care providers to automatically remind the patient to take specific medications, exercise or perform any other task that may be important to managing their disease.

“VitalPoint is an easy-to-use tool that helps support patient care while increasing an agency’s efficiency,” Berge said. “Agencies using the system have the potential to reduce nursing costs as fewer non-essential home visits are required and perhaps — most importantly — help keep that patient in the home rather than in the hospital. But patient care remains top-notch since caregivers can remotely monitor vital signs and symptoms from anywhere at any time of the day.”

Delphi Medical Systems Telehealth and VitalPoint are currently available.

Delphi Medical Systems is a world-class provider of technology, products, and product development and manufacturing for Infusion, Respiratory Care, Vital Signs Monitoring and Power Mobility. Its capabilities stem from Delphi’s vast technology base, product development expertise and manufacturing excellence. Delphi Medical Systems, Inc. is a wholly owned subsidiary of Delphi Automotive Systems, LLC and is part of Delphi Product and Service Solutions. For more information about Delphi Medical Systems, visit www.delphimedical.com.

FORWARD-LOOKING STATEMENT

This press release, as well as other statements made by Delphi may contain forward-looking statements within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, that reflect, when made, the company’s current views with respect to current events and financial performance. Such forward-looking statements are and will be, as the case may be, subject to many risks, uncertainties and factors relating to the company’s operations and business environment which may cause the actual results of the company to be materially different from any future results, express or implied, by such forward-looking statements. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the following: the ability of the company to continue as a going concern; the ability of the company to operate pursuant to the terms of the debtor-in-possession (“DIP”) financing facility; the company’s ability to obtain court approval with respect to motions in the chapter 11 proceeding prosecuted by it from time to time; the ability of the company to develop, prosecute, confirm and consummate one or more plans of reorganization with respect to the Chapter 11 cases; risks associated with third parties seeking and obtaining court approval to terminate or shorten the exclusivity period for the company to propose and confirm one or more plans of reorganization, for the appointment of a chapter 11 trustee or to convert the cases to chapter 7 cases; the ability of the company to obtain and maintain normal terms with vendors and service providers; the company’s ability to maintain contracts that are critical to its operations; the potential adverse impact of the Chapter 11 cases on the company’s liquidity or results of operations; the ability of the company to execute its business plans, including the transformation plan described in this press release, and to do so in a timely fashion; the ability of the company to attract, motivate and/or retain key executives and associates; the ability of the company to avoid or continue to operate during a strike, or partial work stoppage or slow down by any of its unionized employees; and the ability of the company to attract and retain customers. Other risk factors are listed from time to time in the company’s United States Securities and Exchange Commission reports, including, but not limited to the Annual Report on Form 10-K for the year ended December 31, 2004, and its most recent quarterly report on Form 10-Q for the quarter ended September 30, 2005, and current reports on Form 8-K. Delphi disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events and/or otherwise.

Similarly, these and other factors, including the terms of any reorganization plan ultimately confirmed, can affect the value of the company’s various pre-petition liabilities, common stock and/or other equity securities. Additionally, no assurance can be given as to what values, if any, will be ascribed in the bankruptcy proceedings to each of these constituencies. A plan of reorganization could result in holders of Delphi’s common stock receiving no distribution on account of their interest and cancellation of their interests. Under certain conditions specified in the Bankruptcy Code, a plan of reorganization may be confirmed notwithstanding its rejection by an impaired class of creditors or equity holders and notwithstanding the fact that equity holders do not receive or retain property on account of their equity interests under the plan. In light of the foregoing and as stated in its October 8, 2005, press release announcing the filing of its Chapter 11 reorganization cases, the company considers the value of the common stock to be highly speculative and cautions equity holders that the stock may ultimately be determined to have no value. Accordingly, the company urges that appropriate caution be exercised with respect to existing and future investments in Delphi’s common stock or other equity interests or any claims relating to pre-petition liabilities.